Shareholders of YS Biopharma Announce an Extraordinary General Meeting : vimarsana.com

Shareholders of YS Biopharma Announce an Extraordinary General Meeting

/PRNewswire/ -- Shareholders of YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma"), a global biopharmaceutical company dedicated to discovering, developing,...

Related Keywords

Grand Cayman , 00 , Cayman Islands , China , University Of Massachusetts , Massachusetts , United States , Hong Kong , Acton , Maryland , Seattle , Washington , Shaojing , Anhui , Shanghai , American University , District Of Columbia , Liaoning , Jingxian , Hebei , Yi Zhang , Shaanxi , Enan Zhang , Zhejiang , Beijing , Jingshi , Sichuan , Rajit Shetty , Hui Shao , Viren Mehta , James Chang , Rachel Yu , Yun Monica , Yisheng Xingye , Andrew Ledbetter , Chi Keung Peter , Acton Town International , Ohio State University , Nasdaq , Asian Fund For Cancer Research , Liaoning Yisheng Biopharma Co Ltd , Maples Corporate Services , Shanghai University Of International Business , Ys Biopharma Co Ltd , Suffolk University , World Company , Ernst Young , Guangjiyueming Chongqing Business Consulting , Rsys Group , Meeting Of The Company , Piper United Kingdom , Articles Of Association The , Sirnaomics Ltd , Jingshi Shenyang Law Firm , Representative Office , Google , Company Secretary , University Of Birmingham , Jingshi National Law Firm , Yisheng Biotechnology Co Ltd , Exchange Commission , Liaoning University , Brilliance Investments , Apex Pride Global , National Foundation For Cancer Research , Convening Shareholders , Financial Condition , Corporate Services Limited , Acton Town International Limited , All Brilliance Investments Limited , Apex Pride Global Limited , Hopeful World Company Limited , Restated Articles , States Pacific Standard , Jing Xian , Record Date , Proxy Statement , United Kingdom , Extraordinary General Meeting , Standard Time , Shaojing Tong , Outstanding Shares , General Meeting , Return Your Proxy Card , Ordinary Shares , Ordinary Share , Anti Tumor Drug , Liaoning Yisheng Biopharma , Business Consulting , Board Secretary , Joint Company , National Foundation , Cancer Research , Asian Fund , Shanghai University , International Business , Compaq Computer China , Oracle China , Chief Financial Officer , Beijing Jingshi ,

© 2024 Vimarsana